Future prospective and experimental studies of the HSF1 expression and immune cell infiltration in different cancer populations may provide additional insights into the tumor mechanisms and the development of therapeutic strategies targeting HSF1 to improve the therapeutic efficacy of immunotherapy. This evidence concerns the gene HSF1 and neoplasm.